 |
 |

Carcinoid MyopathySerotonin-Induced Muscle Weakness in Man?
Michael Swash, MD, MRCP;
Kathleen P. Fox;
Andrew R. Davidson, MB, MRCP
Arch Neurol. 1975;32(8):572-574.
Abstract
A myopathy, which improved with cyproheptadine hydrochloride therapy, developed in a patient with carcinoid syndrome of ten years' duration. Biopsy examination revealed advanced atrophy of type II muscle fibers, with type I fiber preponderance. Many of the small fibers had degenerated. Carcinoid myopathy may be due to excess circulating serotonin.
Author Affiliations
FILMT
From the Department of Neurology, Section of Neurological Sciences, the London Hospital.
Footnotes
Accepted for publication April 11, 1975.
Reprint requests to the Department of Neurology, the London Hospital, EL 1BB, United Kingdom (Dr. Swash).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Severe Myopathy Associated With Vitamin D Deficiency in Western New York
Prabhala et al.
Arch Intern Med 2000;160:1199-1203.
ABSTRACT
| FULL TEXT
Nonmetastatic manifestations of malignancy: neurological
Grant
Palliat Med 1989;3:181-188.
ABSTRACT
Pathogenesis of Muscular Dystrophies
Rowland
Arch Neurol 1976;33:315-321.
ABSTRACT
|